Relationship between tacrolimus blood level/dose and the genotype of CYP3A5 after lung transplantation
10.3760/cma.j.issn.0254-1785.2014.02.009
- VernacularTitle:肺移植后他克莫司血药浓度和剂量比与受者CYP 3A5基因型的相关性研究
- Author:
Hui XU
;
Ji ZHANG
;
Jingyu CHEN
- Publication Type:Journal Article
- Keywords:
CYP 3A5;
polymorphism;
lung transplantation;
Tacrolimus
- From:
Chinese Journal of Organ Transplantation
2014;35(2):103-105
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the relationship between tacrolimus blood level/dose and the genotype of CYP3A5 at 6th month after lung transplantation.Method Forty-six cases of lung transplant recipients who received the surgery between January 1st,2011 and January 1st,2013 served as the research subjects,and the genotypes of these patients were measured.These patients were divided into 3 groups (CYP 3A5 * 1 * 1,CYP 3A5 * 1 * 3,CYP 3A5 * 3 * 3) according to their different genotypes.The dose of tacrolimus and daily intake were detected at 6th month after surgery in each group,then the level/dose of tacrolimus was calculated.Result In all 46 recipients,5 of them were CYP 3A5 * 1 * 1 homozygous genotype,20 CYP 3A5 * 1 * 3 heterozygous genotype and 21 CYP 3A5 * 3 * 3 homozygous genotype.Under the condition of holding tacrolimus blood level between therapeutic range,there was significant difference in the dose of tacrolimus between the CYP3A5 * 1/ * 1 and * 1/* 3 versus * 3/* 3 genotypes (P＜0.01),but there was no significant difference between CYP3A5 * 1/* 1 genotype and * 1/* 3 genotype.Conclusion Tacrolimus dosing in lung transplant patients is associated with CYP 3A5 gene polymorphisms.
